ADI PEG20

Drug identity checked against registry records

Also recorded as Pegargiminase

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)NCT05712694Polaris GroupPhase 3Terminated2026-05-25Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.